Rundell, Veronica L. M., David L. Geenen, Peter M. Buttrick, and Pieter P. de Tombe. Depressed cardiac tension cost in experimental diabetes is due to altered myosin heavy chain isoform expression. Am J Physiol Heart Circ Physiol 287: H408 -H413, 2004. First published March 4, 2004 10.1152/ajpheart.00049.2004.-Cardiac disease in diabetes presents as impaired left ventricular contraction and relaxation; however, the mechanisms underlying contractile protein dysfunction during the progression of disease are unknown. Accordingly, we assessed Ca 2ϩ -dependent tension development and tension-dependent ATP consumption (tension cost) in a rat model early (6 wk) and late (12 wk) after the onset of diabetes (50 mg/kg iv streptozotocin) using mechanical force-and enzyme-coupled UV absorbance measurements. Myofilament Ca 2ϩ sensitivity and maximal tension were unchanged between groups at either time point. Cross-bridge cycling rate was significantly decreased in diabetes, as indexed by tension cost (early control 5.4 Ϯ 0.4 and early diabetes 4.2 Ϯ 0.3; and late control 6.0 Ϯ 0.2 and late diabetes 4.2 Ϯ 0.2; P Ͻ 0.05). Because rodent models of cardiac disease are confounded by altered myosin isoform distribution, myosin content was determined by SDS-PAGE and densitometry. The cardiac content of ␣-myosin in diabetes was decreased to 41% Ϯ 4.1 at 6 wk and 32.5% Ϯ 2.9 at 12 wk of diabetes (early control 77.8% Ϯ 3.3 and late control 73.6% Ϯ 2.5). Separate control experiments demonstrated a linear decrease in tension cost with decreased ␣-myosin content. Given this, the depression of tension cost in this rodent model of diabetes could be fully explained by the altered myosin isoform distribution.
cross-bridge cycling; cardiac energetics DIABETES MELLITUS is associated with a cardiomyopathy (CM), which develops in the absence of underlying coronary vascular disease in humans and rodents (12, 26) . This CM is associated with impaired left ventricular contraction and relaxation (4, 22) . Because diabetes affects Ͼ15 million Americans and approximately ϳ75% of these individuals will die of cardiovascular disease, it is important to ascertain what specific contractile deficits are present in diabetic CM.
Accordingly, models of experimental diabetes have been generated to explore the molecular alterations that occur in diabetic CM. In brief, excitation-contraction coupling and the kinetics of shortening and relaxation are generally depressed in these preparations, regardless of peak shortening defects (17, 23, 24) . In terms of the energetics of contraction, cross-bridge cycling and Ca 2ϩ sensitivity of Ca 2ϩ -dependent actin-activated MgATPase have been reported to be altered in diabetes (17, 18) . Alterations in maximal tension development have not been described; however, controversy exists with regard to Ca 2ϩ sensitivity of myofilaments in multicellular preparations (1, 17) . Likewise, in isolated single cell preparations there have been reports of normal (17, 24) , increased (28) , and decreased peak shortening (23) . Thus diabetic myocardium is generally recognized to have impaired relaxation and contraction kinetics and cross-bridge cycling kinetics, whereas alterations in cell shortening, Ca 2ϩ sensitivity, and tension development are still controversial.
Experimental models of diabetic CM often employ rodents, which introduces the confounding problem of isoform switching. A particularly problematic issue when one is examining the energetics (20) and power of contraction (14) is that of myosin heavy chain (MHC) isoform content. It has been long recognized that rodent hearts synthesize less ␣-MHC (faster cycling) isoform when exposed to a pathological stimulus (21) . This is true in diabetes as well, where hyperglycemia is known to reduce the ␣-MHC content and promote the presence of ␤-MHC (9). It is clear that there are deficits in cardiac energetics in rodent models of experimental diabetes; however, it is not known whether MHC isoform switching is the sole cause of these deficits or whether there is further underlying contractile dysfunction. Accordingly, the primary goal of this study was to fully characterize the rodent model of diabetic CM in terms of contractile protein isoform content, myofilament function, and cross-bridge cycling kinetics.
METHODS
Experimental models. All subjects were treated and housed in accordance with the Animal Care and Use Committee guidelines at the University of Illinois at Chicago. This study was designed to evaluate possible mechanisms of progressive cardiac disease in a model of rodent diabetes. Therefore, 4-to 6-wk-old male LewisBrown Norway rats were administered a 50 mg/kg dose of streptozotocin (STZ) intravenously to cause experimental insulin-dependent (Type 1) diabetes mellitus. Blood glucose levels were uncontrolled throughout the disease development period because we did not administer supplemental insulin. Age-matched controls were housed alongside the experimental groups and all were allowed food and water ad libitum. To investigate the possible progressive effects of uncontrolled diabetes, animals were euthanized at two time points: 6-and 12-wk post-STZ treatment. To control for the MHC isoform shifts known to confound the study of rat cardiac tissue, a separate group of young animals that express 100% ␣-MHC was treated for short periods of time (0, 6, 11, 16, 21, and 42 days) with propylthiouracil (PTU; 0.8 g/l in the drinking water) to induce various amounts of ␤-MHC protein expression. Right ventricular trabeculae from these hearts were used experimentally to define the relationship between ␤-MHC protein expression, tension cost, and force development.
Mechanical experiments. The animals were anesthetized after intraperitoneal injection of pentobarbital (50 mg), and hearts were rapidly excised. Serum glucose and body and heart weight were obtained at the time of death. Right ventricular trabeculae were dissected free and incubated overnight at 4°C in low-Ca 2ϩ "skinning" solution containing 1% Triton X-100 to allow for chemical permeablization of extracellular membranes (skinning solution) composed of (in mM) 20 EGTA, 10 creatine phosphate, 100 N,N-bis[2-hydroxyethyl]-2-aminoethane sulfonic acid (BES), 5.93 ATP, 6.6 MgCl, and 20.7 potassium proprionate, pH 7.0. After permeabilization, the trabeculae were attached to hooks mounted on a force transducer (model AE 801 SensoNor) and a motor arm (Cambridge) in the experimental apparatus by way of aluminum T-clips, as previously described (7) . Sarcomere length (SL) was set to 2.3 m by laser diffraction. The trabeculae were then exposed to a range of Ca 2ϩ solutions obtained by proportional mixing of activating and relaxing solutions, and the force generated and ATP consumed were measured simultaneously during contraction. ATP consumption was measured as previously described using a UV-coupled optical absorbance method (7) . Individual examples are depicted in Fig. 1A . Briefly, the consumption of ATP is stoichiometrically coupled to NADH consumption. UV absorbance is depicted in the top panels and the matched force trace is shown in the bottom panels. NADH absorbs UV light, whereas its reduced form, NADϩ, does not. It is clear that UV absorbance decreases immediately on incubation of the trabecula in activating levels of Ca 2ϩ (50 (10), assuming an apparent stability constant of the Ca 2ϩ -EGTA complex of 10 6.58 (7) . All measurements were made at 20°C. After each experiment, trabeculae were stored in 1% SDS solution and frozen at Ϫ20°C for later analysis by SDS-PAGE.
Gel electrophoresis. Separation of MHC isoforms was undertaken using SDS-PAGE as described with the following modifications (20) . After each experiment, the trabecula were incubated in 10 l 2ϫ Laemmli sample buffer (Sigma) and sonicated in ice water for 15 min. The samples were then shaken on a vortex for at least 2 h at 4°C, boiled for 5 min at 95°C, and spun in a microcentrifuge at 5,000 rpm for 5 min. The supernatant was loaded onto wells of a discontinuous . Bottom, matched force traces for each trabecula. As the trabecula is incubated in Ca 2ϩ , force is generated and the NADH signal declines. ATP consumption is stoichiometrically coupled to NADH consumption by the actions of the enzymes pyruvate kinase and lactate dehydrogenase; thus the slope of the NADH trace is proportional to ATP consumption. When the trabecula is removed to a relaxing solution, force drops to preactivation levels, and NADH consumption, and therefore ATP consumption, essentially stops. A series of ADP injections (250 pmol), indicated by arrows, are made into the measuring chamber for calibration of the NADH signal. B: Ca 2ϩ -dependent tension relationships plotted after a series of activations of the trabeculae as shown in A. Force has been normalized to trabecular crosssectional area. The data has been fit to a modified Hill equation. Maximum tension development and Ca 2ϩ sensitivity are not different between the two trabeculae. C: tension-dependent ATP consumption for the trabeculae reflected in A and B. ATP consumption has been normalized to trabecular volume. It is apparent that the slope of the linear fit is lower in the diabetic trabecula (control 6.95, R ϭ 0.99; diabetes 3.8, R ϭ 0.99).
slab gel containing 5% acrylamide in the stacking gel and 6.5% acrylamide in the resolving gel. The bis:acrylamide ratio was 100:1. Gels were cast in a large Hoefer apparatus and maintained at 2°C while subjected to a constant current of 20 mA for 30 min, followed by 6 h at 45 mA per gel. After the run, gels were stained overnight with GelCode Blue (Pierce Chemical) and destained in dH 2O for 2 h or until the background was clean. The gel was then scanned in a densitometer and the ␣-MHC-to-␤-MHC ratio was calculated (Kodak 1D).
Data analysis. The results of the mechanical experiments were fit to a modified Hill equation
where F is peak steady-state force (skinned); Fmax is the maximum saturated value F can attain; EC50 is the [Ca 2ϩ ] at which F is 50% of Fmax, and H is the Hill coefficient that represents the slope of the force- [Ca 2ϩ ] relation at EC50. The results from each experiment were fit individually as is shown in Fig. 1B . The fit parameters from each trabecula were pooled and the mean values are reported. Consumption of ATP was normalized to trabecula volume and plotted versus the force/cross sectional area attained during each contraction. Linear regression was used to fit this relationship (cf. Fig. 1C ), the slope of each experimental line fit was pooled, and the mean value is reported as tension cost. Individual fits were pooled to generate the mean value reported. For the 6-wk study, group sizes were n ϭ 11 for both control and diabetic groups. In the 12-wk study, the control group was n ϭ 14, and the diabetic group was n ϭ 11. One trabecula per heart was used for mechanical experiments. Analysis of data was by two-way ANOVA to evaluate the separate and combined effects of diabetes and time using SPSS version 10.0 software, with the exception of the heart weight-to-tibial length ratio in the late diabetes cohort, which was analyzed by Student's t-test. The data are reported as means Ϯ SE. Significant values are reported at P Ͻ 0.05.
RESULTS

Evaluation of model.
Characteristics of the animals treated with STZ are summarized in Table 1 . Circulating glucose levels, measured at time of death, were increased threefold over controls (P Ͻ 0.001). Total body weight was lower in diabetes groups at 6 wk (17%) and further decreased (25-45%) at the 12-wk time point. In acknowledgement of the decrease in body weight, the ratio of wet heart weight to tibial length was determined in the 12-wk study. This comparison documented no change in relative heart size in the late diabetes group, and thus there was no hypertrophy present in diabetes.
Impact of diabetes on contraction. Myofilament responsiveness to Ca 2ϩ was measured and the data were fit to Eq. 1 (see METHODS). Mean fit parameters are summarized in Table 2 and illustrated graphically in Fig. 2 . It is clear that there was no decrease in maximal tension development in trabecula from diabetes animals at either time point. In addition, there were no significant differences in EC 50 in early or late diabetes, indicating there was no change in myofilament Ca 2ϩ sensitivity. Furthermore, there were no differences in Hill coefficient between groups at either time point, indicating the cooperativity of thin filament activation was unchanged in diabetes.
Impact of diabetes on cross-bridge cycling kinetics. The two-state model of cross-bridge cycling predicts that the overall steady-state rate of the cross-bridge cycle is proportional to either the rate of cross-bridge attachment ( f ) or detachment (g) (3, 16) . To assess the impact of diabetes on cross-bridge cycling kinetics, we determined tension-dependent ATP consumption, tension cost, in trabeculae in all groups. In terms of the contraction energetics, tension cost is proportional to g (16) . Mean fit values for all energetic parameters are summarized in Table 3 . The maximal rate of ATP consumption was significantly depressed in diabetes both early and late, by 16% and 30%, respectively. Tension cost, the relationship between developed tension and ATP consumption, as described previously, was significantly and progressively depressed in both early and late diabetes, by 21% and 30%, respectively, from their control groups. This indicates a more economical use of ATP for force generation in diabetes.
Because there was no impact of diabetes on maximal tension development, the resultant depression of tension cost and ATP consumption must be related to the intrinsic rate of ATP Values are means Ϯ SE; n ϭ 11 animals per group. Diabetic animals had significantly higher blood glucose at both time points. Body weight was significantly lower in the diabetes groups at both time points as well. Heart weight was normalized to body size by comparing the wet heart weight with tibial length in the late (12 wk) study. With the use of Student's t-test, no significant difference was found, indicating that this model did not show cardiac hypertrophy. *P Ͻ 0.05, by two-way ANOVA comparing diabetes vs. control and length of time. Values are means Ϯ SE. Tmax, maximum tension. EC50, Ca 2ϩ concentration at which peak steady-state force is 50% of maximum value. There were no significant differences between groups at either time point. Fig. 2 . Ca 2ϩ -dependent tension development is unchanged in diabetes. Hill fits of the mean data are summarized in Table 2 . There are no significant alterations in the shape or position of the Ca 2ϩ -dependent force relationships in diabetes.
hydrolysis. To investigate the role of increased ␤-MHC expression in the depression of cross-bridge cycling kinetics, trabeculae were analyzed by SDS-PAGE to determine relative MHC isoform content. A sample of the separation is shown in Fig. 3 . Mean ␣-MHC content is listed in Table 3 . In addition, a subset of young animals treated with PTU for 0, 6, 11, 16, 21, and 42 days were generated and trabeculae from these animals were used to investigate the linearity of the relationship between ␣-MHC protein content and tension cost. After quantification of the relative ␣-and ␤-MHC content for each trabecula, we determined the relationship of tension cost to ␣-MHC content by linear regression analysis. Figure 4 illustrates a direct linear proportionality between ␣-MHC content and tension cost in the PTU-treated group. Furthermore, all of the data were clustered around a common regression line. Therefore, we conclude that the depression of steady-state cross-bridge turnover was directly related to increased ␤-MHC expression in this model of cardiac disease.
DISCUSSION
The model of diabetes used in this study has been employed by us and by others (1, 14, 15) and the physical characteristics of the diabetes animals mirror those previously reported. Blood glucose levels were increased greater than threefold at all time points after STZ treatment and progressive weight loss was seen over the 12 wk of observation. In general, diabetes in the absence of hypertension is not associated with cardiac hypertrophy, and this finding was recapitulated in the animals in the present study in that heart weight to tibial length ratio was constant. In addition, the ␣-to ␤-MHC ratio in the diabetic animals was decreased, as has been previously reported (9) . These details are important in that they provide reassurance that the animals studied were phenotypically similar to those described in the literature.
Myofilament function was not depressed, as indexed by maximal tension development, in either early or late diabetes.
The present findings of no alteration in maximal isometric tension development are consistent with other reports in diabetes (1, 11, 15) . Likewise, it is consistent with the unchanged peak shortening of beating isolated cardiac myocytes from diabetic animals reported previously (17) . There is a paucity of experiments that demonstrate changes in maximal isometric tension development in skinned fiber preparations. The majority of experiments demonstrate no change in maximal tension development but report a slowing in the kinetics of contraction, namely time to peak shortening and relaxation parameters, in diabetes (11) . In intact, working heart preparations there are reports of decreased left ventricular peak pressure development in diabetes that is exacerbated by hypertension (6, 25) . Ren and Bode (23) and Davidoff and Ren (5) report a slight decrease in peak shortening of unloaded intact myocytes from the spontaneously diabetic BioBreed rat model and the STZ-induced diabetes model, respectively; however, this was not recapitulated in other experiments (28) . Thus, whereas there is still variation in the literature, in this study we report no deleterious effects of experimental diabetes on the maximal myofilament force-generating capability of small rodent myocardium.
The myofilament Ca 2ϩ sensitivity was unchanged in this study. Akella and colleagues (1) reported decreased Ca 2ϩ sensitivity at short SL between control and diabetic subjects, although those measurements were made at a shorter SL (1.9 m) than reported here (2.3 m). However, it is unlikely that that factor alone can explain the difference because other investigators have measured the tension-Ca 2ϩ relationship in diabetes in skinned trabecula preparations and found no difference in sensitivity at SL 1.9 m (17). Myofilament forceCa 2ϩ relations measured in intact, nonskinned isolated cardiac muscle by this same group also demonstrated no alteration in Fig. 3 . SDS-PAGE illustrating the separation between ␣-and ␤-myosin heavy chain (MHC). Example of MHC separation from early and late controls and diabetes. Each trabecula used in mechanical experiments was reserved and subjected to SDS-PAGE. The top ␣-MHC band can be clearly resolved from the lower ␤-band by densitometry. The ␣-MHC content was determined for each trabecula after experimentation. *P Ͻ 0.05 by two-way ANOVA. Ca 2ϩ sensitivity. Hofmann and colleagues (15) also reported decreased Ca 2ϩ sensitivity in diabetes; however, in their study, the control myocytes had an average SL of 2.45 m in full-activating solution, whereas diabetes myocytes attained an average SL of 2.37 m; therefore the EC 50 may have been artificially decreased as a result of poor SL control, thereby magnifying a possible effect of diabetes. In addition, Akella and colleagues (1) demonstrated an enhanced length dependency in diabetes. In our study, a small subset of trabeculae were studied at short SL (2.0 m) to investigate lengthdependent activation. In early diabetes there was a nonsignificant trend toward decreased length-dependent activation, which is in contrast to that reported previously. In late diabetes, there was neither an increase in EC 50 or myofilament lengthdependent activation; thus, whatever the mechanism of increased Ca 2ϩ sensitivity in diabetes, this was transient and may well have been an early adaptation to hyperglycemia and not a defining property of established diabetic cardiomyopathy. Nevertheless, the reasons for differences between earlier findings and those reported here are not entirely clear.
In terms of cross-bridge cycling kinetics, there was a significant decrease in maximal ATP consumption rate and tension cost that was present in early and late diabetes. Decreases in cross-bridge cycling kinetics have been reported previously (13, 17, 18) . That these decreases correlated with decreasing ␣-MHC content in these hearts leads us to conclude that the depression of cross-bridge cycling kinetics was directly related to diabetes-induced expression of ␤-MHC in rat myocardium. It has been reported that there is an increase in ␣-skeletal actin mRNA expression in rodent models of diabetes (8) . No published studies have indicated an increase in ␣-skeletal actin protein in myocardium as a result of diabetes, although there are reports of such increases in human cardiac disease (27) . Recent investigations on the impact of ␥-enteric actin on tension cost in our laboratory have found a depressed tension cost with expression of the ␥-enteric actin that could not be explained solely by the concomitant increased expression of ␤-MHC in those animals (20) . However, we did not find a depressed tension cost that could not be accounted for by increased ␤-MHC expression in the present study, supporting the notion that increased ␣-skeletal actin protein expression did not occur in our study, nor contributed to the alteration in cross-bridge cycling rate. Nevertheless, we cannot fully exclude this possibility because the concentration of ␣-skeletal actin protein was not investigated directly in this study.
Diabetic cardiomyopathy is manifest as altered contraction and relaxation, which is generally associated with altered Ca 2ϩ handling ability of the myocyte and most likely the myofilaments. Electrophysiological data has demonstrated a lengthening of the Ca 2ϩ transient in diabetes, as well as defects in sarcoplasmic reticulum Ca 2ϩ handling (2, 4, 17) . This altered Ca 2ϩ handling and relaxation rate can be seen nearly immediately, within days of onset of diabetes and even in normal cells cultured in media containing high glucose and low insulin (6, 24) . Thus the immediate effects of diabetes are very clearly detrimental, and yet the myocardium adapts so that it can function in the face of this homeostatic alteration. Transcription of ␤-MHC begins very early in disease development; however, due to a long half-life for MHC significant protein replacement takes weeks to appear (8) . Thus it appears that in the face of reduced energy supply, as a result of hypoinsulinemia in this model of diabetes, the rat cardiomyocyte attempts to become as economical as possible while still producing enough force to meet the constant demand for oxygenated blood from the tissues. Accordingly, MHC isoform expression shifts to preferentially ␤-MHC and cross-bridge cycling kinetics are likewise depressed.
Although the data demonstrated in this study clearly establish the primacy of the myosin isoform shifting in rodent models of disease, the relevance of this to diabetic cardiomyopathy in larger animals and in humans, where myosin isoform shifting is not prominent, is less clear. Hence, caution should be exercised to extrapolate our present results obtained in rats to diabetes in larger mammals, such as humans. Moreover, the present study evaluated a model of Type I diabetes (hypoinsulinemia), and it is similarly unclear whether hyperglycemia and insulin excess would have similar effects on muscle mechanics. It is quite possible that alternate adaptational mechanisms, perhaps related to posttranslational modification of thin filament proteins by activated PKC (19) , might provide a mechanism for myofilament desensitization to Ca 2ϩ and reduction of the energy costs of contraction in these alternate circumstances. Confirmation of this awaits analogous studies in larger animal models as well as rodent models of Type II diabetes.
